Enteric fever, commonly known as typhoid fever, is a systemic infection primarily caused by Salmonella Typhi or Salmonella Paratyphi. Despite advances in healthcare, it remains a significant public health issue, especially in developing countries. Early diagnosis and effective management are critical in reducing morbidity and mortality associated with the disease.
Diagnosis of enteric fever relies on clinical presentation, culture techniques, and serological tests. Clinical suspicion should be high in patients presenting with prolonged fever, abdominal pain, and constipation or diarrhea. Blood cultures remain the gold standard for diagnosis, with a sensitivity of 40-60%. However, their utility is limited by the necessity of specialized equipment and trained staff. Serological tests, such as the Widal test, offer a more accessible alternative but suffer from low specificity and sensitivity.
Recent advances have aimed at improving diagnostic accuracy and speed. Polymerase chain reaction (PCR) techniques targeting specific genes of Salmonella Typhi and Paratyphi have shown promising results. Rapid diagnostic tests (RDTs) based on the detection of specific antigens or antibodies are also being developed and evaluated.
Management of enteric fever involves both supportive care and antibiotic therapy. Fluid and electrolyte management is crucial in patients with severe disease. Antibiotic choice should be guided by local susceptibility patterns. Empiric therapy with a third-generation cephalosporin or fluoroquinolone is often initiated until culture results are available. In the case of drug-resistant strains, newer agents like azithromycin have shown efficacy.
In conclusion, enteric fever remains a significant health challenge necessitating prompt diagnosis and effective management. Advancements in diagnostic techniques and the judicious use of antibiotics are vital in reducing the disease burden. Continued research and development into improved diagnostic tools and therapeutic strategies are crucial in the fight against this enduring disease.
1.
A Lot Can Be Said About You by Including Yourself in Photos.
2.
A new blood test greatly increases the ability to detect cancer.
3.
Novel biomarker has potential for predicting and treating skin cancer metastasis
4.
Anti-PD-L1 Plus Targeted Agent No Better Than Chemo for Resistant NSCLC
5.
No Survival Gain With Preoperative CRT Plus Perioperative Chemo for Gastric Cancer
1.
Preventing Heparin Induced Thrombocytopenia: Tips for Successful Anticoagulation Therapy
2.
Preventing Treatment-Related Secondary Malignancies: Evidence-Based Strategies for Clinical Practice
3.
Contemporary Frameworks in Oncology Across Clinical Settings
4.
What is Mullerian and How Does it Affect Your Health
5.
The Expanding Horizon of PSMA: A Comparative Clinical Review of Theranostics in Prostate Cancer and Beyond
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Understanding Common Causes of Abnormal Blood Counts
2.
Understanding Early Relapse in B-cell ALL: Rates, Risks, and Common Sites
3.
CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion
4.
Understanding Cancer: Early Detection and Treatment
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation